Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · April 28, 2023

Characterization of the Genetic Features of NPM1-Mutated Myeloid Sarcoma and NPM1-Mutated AML

Leukemia and Lymphoma


Additional Info

Disclosure statements are available on the authors' profiles:

Leukemia and Lymphoma
Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group
Leukemia and Lymphoma 2023 Mar 24;[EPub Ahead of Print], M Ramia de Cap, LP Wu, C Hirt, GA Pihan, SS Patel, W Tam, CE Bueso-Ramos, R Kanagal-Shamanna, PW Raess, A Siddon, D Narayanan, EA Morgan, GS Pinkus, EF Mason, ED Hsi, HJ Rogers, L Toth, K Foucar, SN Hurwitz, A Bagg, A Rets, TI George, A Orazi, DA Arber, RP Hasserjian, OK Weinberg

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading